New Diagnostic Approaches in the Management of Inflammatory Lung Diseases

Integrated Precision Medicine Platform · Не указано

ID реестра
NCT07723638
Фаза
Не указано
Статус
Набор еще не начат
Препарат / вмешательство
Integrated Precision Medicine Platform
Спонсор
Fondazione Don Carlo Gnocchi ETS
Начало
2026-09-01
Набор участников
200

Об исследовании

Inflammatory lung diseases, including chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), are major causes of morbidity and mortality worldwide. Their development and progression are influenced by environmental exposures, such as cigarette smoking and air pollution, as well as genetic susceptibility. Despite advances in disease management, early diagnosis, accurate differential diagnosis, personalized treatment, and continuous monitoring remain significant clinical challenges. This project aims to improve the management of inflammatory lung diseases through the development and validation of innovative diagnostic, monitoring, and therapeutic approaches. The study will identify and validate multi-omics biomarkers for the differential diagnosis and prognosis

Открыть NCT07723638 на ClinicalTrials.gov →

Медицинская оговорка. Эта страница обобщает публичные данные исследования NCT07723638 только для информации. Это не медицинская рекомендация, не одобрение и не предложение участия. Проверяйте детали на ClinicalTrials.gov и у квалифицированного врача.